Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 2Sarcoma 1Prostatic Neoplasms 1Primary Care 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Hematologic Neoplasms 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Colorectal Neoplasms 1

Interventions

Colonoscopy 44Standard of Care 29Early Intervention, Educational 23Methods 22Blood Specimen Collection 21Exercise 20Educational Status 19Interviews as Topic 13Surveys and Questionnaires 12Practice Guidelines as Topic 12Patient Navigation 12Counseling 12Endoscopic Mucosal Resection 10Drug Therapy 10Oxaliplatin 9Irinotecan 8Fluorouracil 8Surgical Procedures, Operative 7Preoperative Exercise 7Lidocaine 7Bevacizumab 7Therapeutics 6Resistance Training 6Occult Blood 6Narrow Band Imaging 6Mass Screening 6Leucovorin 6Diet 6Decision Support Techniques 6Control Groups 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Colorectal Neoplasms × Darbepoetin alfa × Clear all
NCT06184867 2026-03-06

CATALYST

Rutgers, The State University of New Jersey

Phase NA Completed
50 enrolled
BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡